Patient Satisfaction & Quality Of Life in Patients With Cervical Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1938 participants

Study Classification

OBSERVATIONAL

Study Start Date

1999-07-01

Study Completion Date

2020-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary Objectives:

1. To compare levels of patient anxiety, pain, and satisfaction associated with optical spectroscopy procedures and MDC with the levels associated with colposcopically-directed biopsy in the cervical cancer diagnostic setting and with Papanicolaou smear in the screening setting. This aim will be addressed in Studies A and A' -- Procedure-Related Distress and Patient Satisfaction.
2. To evaluate differences in psychological distress, satisfaction, and adherence to treatment in the two arms of a randomized trial; one group will be diagnosed with usual care procedures (Papanicolaou smear and colposcopically-directed biopsy) plus optical spectroscopy and the second will receive usual care. Aim 2 will be accomplished in Study B -- Psychological Distress, Satisfaction, and Adherence Outcomes in a Randomized Trial of Optical Spectroscopy.
3. To assess the psychosocial and behavioral impact of a false positive screening result. This will be done in Study C -- Impact of False Positive Screening Test on Psychological Distress and Future Screening Intentions.
4. To assess provider receptivity to optical spectroscopy. Aim 4 will be accomplished in Study D -- Survey of Health Care Providers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sexual Functioning in Cervical Cancer Survivors

NCT00522223

Cervical Cancer

COMPLETED

Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients

NCT00788216

Cervical Cancer

COMPLETED

Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

NCT06843720

HR-HPV Testing

RECRUITING NA

Psycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs

NCT06500767

Physiological Stress HPV Infection Papilloma Viral Infection

RECRUITING

Living With Cervical Cancer: Assessing Utilities Associated With Common Treatment Complications

NCT01039493

Cervical Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Randomized Clinical Trial:

Participants in this study will be interviewed before and after they see the doctor for their first visit. They will be asked about their moods and the tests used to detect cervical cancer. They will also be asked about their symptom, how it is affecting their lives, and their satisfaction with their visit.

Participants will be called approximately 2 weeks, 6 weeks, and 3 months after their appointments to answer questions about their health and quality of life, and the test and treatment they received. In addition, the participants will complete assessments at the 6, 12, 18, and 24 month clinic visits. If participants do not return for these follow-up appointments, the research staff will attempt to contact the participants to do brief interview by phone.

Research staff will also review participant's medical records and gather information on diagnosis, treatment plans and adherence.

This is an investigational study. A total of 360 patients will take part in this multicenter study. About 180 participants at M. D. Anderson will take part in this study.

Studies A and A Prime:

Participants in this study will be interviewed before they see the doctor. They will be asked about their moods and the tests used to detect cervical cancer.

During the medical tests, participants will rate their pain and how tense they are. Someone will watch them to see whether they are upset or in pain. After they see the doctor, participants will be interviewed again about their mood and how much they liked or did not like the test.

Some participants will be interviewed about their opinion of the test at the appointment when they receive their test results. Some participants will complete the Sequelae of LEEP/biopsy and medication use questionnaire. Some participants will be called 7 to 14 days and/or three months after their appointments. Some participants may answer some of the questions on a computer as well as in an interview. They will be asked to answer questions about their moods and about getting tests to detect cervical cancer. A sample of the participants will be selected to have their results visit tape recorded and to answer a few questions about what the doctor told them.

Participants may be contacted to participate in discussion groups about tests for cervical dysplasia. Participation in the discussion groups is voluntary. Research staff will also review participant's medical records and gather information on diagnosis, treatment plans and adherence.

This is an investigational study. A total of 3980 patients will take part in this multicenter study. About 2400 participants at M. D. Anderson will take part in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychosocial Cervical Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Women who are eligible to participate in a study of the technical feasibility of optical spectroscopy will be invited to participate in this study.

Questionnaire

Intervention Type BEHAVIORAL

Questionnaire

A'

Women who are eligible to participate in a study of the technical feasibility of optical spectroscopy will be invited to participate in this study.

Questionnaire

Intervention Type BEHAVIORAL

Questionnaire

B

Patients who have consented to participate in a randomized trial of optical spectroscopy.

Questionnaire

Intervention Type BEHAVIORAL

Questionnaire

C

Women who are eligible to participate in a study of the technical feasibility of optical spectroscopy will be invited to participate in this study.

Questionnaire

Intervention Type BEHAVIORAL

Questionnaire

D

Health care providers.

Questionnaire

Intervention Type BEHAVIORAL

Questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Studies A, A', and pilot tests

* Eligible to participate in Project 2
* Over 18
* Referred for an abnormal pap or has no history of abnormal pap
* Consented to participate in the patient outcomes project.
2. Study B

* Consented to participate in Project 3
* Over 18
* Referred for an abnormal pap
* Consented to participate in the patient outcome project.
3. Study C

* Same as Study B.
4. Study D

* Members of the American Society for Colposcopy and Cervical Pathology (ASCCP).